Literature DB >> 17664870

When tinnitus loudness and annoyance are discrepant: audiological characteristics and psychological profile.

Wolfgang Hiller1, Gerhard Goebel.   

Abstract

This study evaluates sociodemographic and clinical characteristics of patients reporting discrepant levels of tinnitus loudness and annoyance. 4958 subjects recruited from a national tinnitus association completed a comprehensive screening questionnaire including Klockhoff and Lindblom's loudness grading system and the psychometric Mini-TQ (Tinnitus Questionnaire). There was a moderate correlation of 0.45 between loudness and annoyance. Of the subjects reporting very loud tinnitus, about one third had only mild or moderate annoyance scores. They were not different from those with high annoyance regarding age, gender and tinnitus duration, but annoyance was increased when subjects had additional hearing loss (OR = 1.71), vertigo/dizziness (OR = 1.94) or hyperacusis (OR = 4.96). Another significant predictor was history of neurological disease (OR = 3.16). Subjects reported low annoyance despite high loudness more often if not feeling low/depressed and not considering themselves as victims of their noises. A specific psychological profile was found to characterize annoyed tinnitus sufferers. Permanent awareness of the noises, decreased ability to ignore them and concentration difficulties were reported frequently even when overall annoyance scores were comparatively low. It is concluded that the coexistence of tinnitus with hearing loss, vertigo/dizziness and hyperacusis as complicating otological conditions seems to be of clinical relevance for the prediction of high annoyance levels. Tinnitus loudness and annoyance are not necessarily congruent and should be assessed separately. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17664870     DOI: 10.1159/000106482

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  39 in total

1.  An active loudness model suggesting tinnitus as increased central noise and hyperacusis as increased nonlinear gain.

Authors:  Fan-Gang Zeng
Journal:  Hear Res       Date:  2012-05-26       Impact factor: 3.208

2.  Right-Ear Advantage for Speech-in-Noise Recognition in Patients with Nonlateralized Tinnitus and Normal Hearing Sensitivity.

Authors:  Yihsin Tai; Fatima T Husain
Journal:  J Assoc Res Otolaryngol       Date:  2017-11-27

3.  Psychological comorbidity in patients with chronic tinnitus: analysis and comparison with chronic pain, asthma or atopic dermatitis patients.

Authors:  N Zirke; C Seydel; A J Szczepek; H Olze; H Haupt; B Mazurek
Journal:  Qual Life Res       Date:  2012-03-20       Impact factor: 4.147

Review 4.  [Smartphone app-supported approaches to tinnitus therapy].

Authors:  G Hesse
Journal:  HNO       Date:  2018-05       Impact factor: 1.284

5.  [Hearing aids, implantable hearing aids and cochlear implants in chronic tinnitus therapy].

Authors:  H Olze; T Zahnert; G Hesse
Journal:  HNO       Date:  2010-10       Impact factor: 1.284

6.  [Examination of signals for tinnitus sound therapy. Effects of signal dynamics on sound acceptance and tinnitus masking].

Authors:  S Schreitmüller; H von Wedel; M Walger; H Meister
Journal:  HNO       Date:  2013-01       Impact factor: 1.284

7.  Long-term effects of the "Heidelberg Model of Music Therapy" in patients with chronic tinnitus.

Authors:  Heike Argstatter; Miriam Grapp; Elisabeth Hutter; Peter Plinkert; Hans Volker Bolay
Journal:  Int J Clin Exp Med       Date:  2012-08-22

8.  [Tinnitus and psychiatric comorbidities].

Authors:  G Goebel
Journal:  HNO       Date:  2015-04       Impact factor: 1.284

9.  The Emotional and Functional Impact of the Type of Tinnitus Sensation.

Authors:  John Moring; Anne Bowen; Jenifer Thomas; Lindsay Bira
Journal:  J Clin Psychol Med Settings       Date:  2016-09

10.  Efficacy and safety of bilateral continuous theta burst stimulation (cTBS) for the treatment of chronic tinnitus: design of a three-armed randomized controlled trial.

Authors:  Carola Arfeller; Reinhard Vonthein; Stefan K Plontke; Christian Plewnia
Journal:  Trials       Date:  2009-08-21       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.